Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Dr Lalchandani Labs Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹6.48 |
|---|---|
| Day's Range | ₹5.97 - ₹6.48 |
| Open | ₹5.97 |
| 52 Week Range | ₹06.28 - ₹21.22 |
| Volume | 1,48,000 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 9.59 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 86.10 |
| TTM EPS (₹) | 0.07 |
| P/E Ratio | 10.61 |
| Book Value(₹) | 0.38 |
| PAT Margin (%) | 9.37 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 3.61 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 44.54 |
| Expenses | N/A | N/A |
| PBT | N/A | 4.02 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 4.17 |
About Dr Lalchandani Labs Ltd.
| Founded | 2011 |
|---|---|
| Managing Director | Arjan Lalchandani |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,64,271.32 | 1,942.85 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,26,842.90 | 8,500.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,999.88 | 4,876.30 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,23,151.56 | 8,595.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,20,099.46 | 1,173.00 | 835.50 - 835.50 |
| Cipla Ltd. | 1,18,071.78 | 1,461.00 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,03,549.99 | 2,261.00 | 1,875.00 - 1,875.00 |
| Lenskart Solutions Ltd. | 1,02,019.00 | 596.00 | 0.00 - 0.00 |
| Mankind Pharma Ltd. | 1,00,137.07 | 2,418.00 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,00,073.46 | 1,206.00 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Alivus Life Sciences informs about newspaper publication
Lincoln Pharmaceuticals informs about un-audited financial results
Global Longlife Hospital and Research informs about disclosure
Thyrocare Technologies informs about disclosure
Max Healthcare Institute informs about grant of options under ESOS
Max Healthcare Institute has informed that Nomination and Remuneration Committee (‘NRC’) of the Company in its meeting held today, August 13, 2026, has approved the grant of 3,61,827 stock options to eligible employees under Max Healthcare Institute - Employee Stock Option Scheme 2022. Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. The NRC meeting commenced at 7.50 am (IST) and concluded at 8.20 am (IST). This disclosure will also be hosted on Company's website: ww.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Dr Lalchandani Labs Ltd. is ₹6.48 as of 2026-08-13.
The market capitalisation of Dr Lalchandani Labs Ltd. is ₹5.42 as of 2026-08-12.
The 1-year return of Dr Lalchandani Labs Ltd. is -7.69% as of 2025-08-04.
The P/E ratio of Dr Lalchandani Labs Ltd. is 10.61 as of 2026-08-13.
The 52-week high and low of Dr Lalchandani Labs Ltd. are ₹21.22 and ₹6.28, respectively, as of 2026-08-13.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
